TCL Archive Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.” October 29, 2004
TCL Archive NCI Initiatives: Two RFAs Planned In New Technologies for Molecular Biology December 6, 1996
TCL Archive Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival January 31, 2014